BioNTech Squares Off with Moderna in High-Stakes Patent Dispute
Published on: Feb. 20, 2026, 7:18 p.m. | Source: Devdiscourse
BioNTech has filed a lawsuit against Moderna, alleging patent infringement by Moderna's COVID-19 vaccine mNEXSPIKE, approved in 2025. The legal battle highlights ongoing patent disputes in the biotech sector over mRNA vaccine technology. BioNTech aims to protect its innovations, while Moderna promises a robust defense.
